Regulatory reprieve with Brexit delay
An EU-granted extension for Brexit means short-term clarity for biopharma companies expecting EMA or European Commission decisions before the new
Gathering data...
An EU-granted extension for Brexit means short-term clarity for biopharma companies expecting EMA or European Commission decisions before the new